BRESAGEN
BresaGen is a developer of proteins and peptides, especially biogenerics. In October 2006, BresaGen was sold to Hospira Inc of the US, and Paragon made a 2.35x return on investment, and 135% IRR. Hospira acquired the company to further develop BresaGen’s intellectual property, and to distribute its products in the US.
BRESAGEN
Industry:
Biopharma Biotechnology
Address:
Thebarton, South Australia, Australia
Country:
Australia
Website Url:
http://www.bresagen.com.au
Status:
Closed
Contact:
+61882342660
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Euro
Investors List
Paragon Private Equity
Paragon Private Equity investment in Private Equity Round - BresaGen
More informations about "BresaGen"
BresaGen - Crunchbase Company Profile & Funding
BresaGen is a developer of proteins and peptides, especially biogenerics. In October 2006, BresaGen was sold to Hospira Inc of the US, and Paragon made a 2.35x return on investment, …See details»
BresaGen as a world-leader in gene biotech from …
Adelaide's BresGen company had its era of leading the world in aspects of gene technology from the 1980s fade away in 2006 when it accepted a takeover offer for BresaGen by Hospira Holdings (S.A.) Pty Ltd, a wholly-owned subsidiary …See details»
BresaGen - Overview, News & Similar companies | ZoomInfo.com
View BresaGen (www.bresagen.com.au) location in South Australia, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Bresagen | Scientist.com
Bresagen.com.au: Headquarters: Adelaide, SA, AU Company Type: Small Business (1-10M TTM Revenue) Description Sites BresaGen is a biotechnology company that is focused on the …See details»
Bresagen pulls plug after three leave board - The Age
Jan 21, 2004 The corporate failure followed the resignation of three of six Bresagen directors late on Monday, including the chairman, after a split opening up between board members over …See details»
BresaGen - Ventures & Markets - LONGECITY
Jun 14, 2005 BresaGen - posted in Ventures & Markets: BresaGen Using a proprietary bacterial expression system, BresaGen has established cost-effective technology to express and purify …See details»
Bresagen restructure and relisting plans announced
Bresagen's administrators have reached an in-principle agreement with Queensland-based public unlisted biotech company CBio for the restructure and relisting of the company. Bresagen …See details»
BresaGen wins FDA approval for catheter - LabOnline
Aug 8, 2002 In addition to the catheter technology, BresaGen has customised imaging software to allow tracking of the catheter during implantation to ensure precise cell delivery to targeted …See details»
BresaGen - Funding, Financials, Valuation & Investors - Crunchbase
Aug 16, 2005 BresaGen is a developer of proteins and peptides, especially biogenerics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
BresaGen Limited (BGN) - Share Price and Research - Intelligent …
Jan 8, 2007 BresaGen Limited (BGN) Overview. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Find …See details»
BresaGen goes into voluntary administration - LabOnline
Jan 20, 2004 Carter said the company would continue to trade, and the voluntary administration would not affect BresaGen's US operations. He said "a number of options" were available to …See details»
BresaGen in Adelaide adds stem cell therapy applied to disease, …
It also enabled BresaGen to set up laboratory operations in the United States of America (USA) with an enticing deal from Georgia University in Atlanta. In December 2000, BresaGen …See details»
BresaGen - Products, Competitors, Financials, Employees, …
NovoCell, Inc./BresaGen is a stem cell engineering company dedicated to creating, delivering, and commercializing cell and drug therapies to treat diabetes and other chronic diseases. …See details»
Bresatec biotech jumps from pigs to horses in taking its Adelaide ...
In 2003, BresaGen bought the XeriJect drug delivery platform from Unoted States company AlgoRx Pharmaceuticals. Dr Steve Prestrelski was a key inventor of the XeriJect technology …See details»
BresaGen Buying CytoGenesis, Merging Cell Therapy Programs
Sep 6, 2000 He said that the acquisition gave BresaGen a "defined and accelerated path to human trials." Stem cell research is being actively pursued by biotech companies around the …See details»
BresaGen's Adelaide research lead in gene biotechnology brought …
BresaGen president/chief executive Dr John Smeaton said the technology that the Adelaide company brought to cloning a pig in 2001 to clone was significantly different from that used to …See details»
Biotech pioneer BresaGen resurrected as service company
BresaGen is already selling hGH to the Middle East, and is expanding into China, India and other markets, and is developing interferon alpha to treat chronic hepatitis C, and G-CSF for …See details»
Stem-cell giveaway proposed as confusion reigns over cell count
BresaGen, a company based in Adelaide, Australia, and ES Cell International (ESI) in Singapore say they plan to give their cells away to publicly funded scientists.See details»
BresaGen, Cythera complete merger - LabOnline
Jun 28, 2004 Bresagen (ASX:BGN) will own about 30 per cent of the combined entity and have a seat on the board. Bresagen and Cythera initially announced the deal in November last year, …See details»
BresaGen sells its catheter technology - labonline.com.au
BresaGen (ASX:BGN) has assigned its cell delivery catheter licenses to North American company NexGen Technologies for about $380,000 plus a four per cent share in NexGen. The company …See details»